Canada markets open in 7 hours 22 minutes

Tian'an Pharmaceutical Co., Ltd. (TNPH)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00660.0000 (0.00%)
At close: 02:47PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 979.64k
Enterprise Value 979.64k
Trailing P/E 5.64
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.63
Price/Book (mrq)1.20
Enterprise Value/Revenue 0.09
Enterprise Value/EBITDA 0.23

Trading Information

Stock Price History

Beta (5Y Monthly) -0.90
52-Week Change 3-73.49%
S&P500 52-Week Change 326.43%
52 Week High 30.0249
52 Week Low 30.0028
50-Day Moving Average 30.0066
200-Day Moving Average 30.0080

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 5N/A
Implied Shares Outstanding 62.62B
Float 8N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2007
Most Recent Quarter (mrq)Dec 31, 2007

Profitability

Profit Margin 29.51%
Operating Margin (ttm)27.42%

Management Effectiveness

Return on Assets (ttm)18.01%
Return on Equity (ttm)25.12%

Income Statement

Revenue (ttm)10.65M
Revenue Per Share (ttm)0.76
Quarterly Revenue Growth (yoy)73.10%
Gross Profit (ttm)N/A
EBITDA 4.31M
Net Income Avi to Common (ttm)3.14M
Diluted EPS (ttm)0.0000
Quarterly Earnings Growth (yoy)71.20%

Balance Sheet

Total Cash (mrq)8.23M
Total Cash Per Share (mrq)0.59
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)14.23
Book Value Per Share (mrq)1.03

Cash Flow Statement

Operating Cash Flow (ttm)2.56M
Levered Free Cash Flow (ttm)2.34M